Respiratory Care Devices Market Overview
Global respiratory care devices market was valued at $12,890 million in 2015, and is poised to reach $21,300 million by 2022, registering an estimated of CAGR 7.4% during the forecast period. Respiratory care devices are used for diagnosis, monitoring, and treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. These devices provide enhanced care to patients suffering from such acute and chronic respiratory diseases. The report analyzes the respiratory care devices market on the basis of product type, end user, and geography.
According to the AMR analysis, the pulse oximetry market is expected to grow at a steady rate throughout the forecast period. Smart pulse oximeters devices have gained popularity as compared to other respiratory care devices in the recent years. It has become a vital tool for clinicians for continuous monitoring of a patient’s arterial oxygen saturation (SaO2) by calculating an estimate of the SaO2 (known as the SpO2) using an algorithm, and displaying the readout. Several companies have focused on developing cost-effective pulse oximeters to sustain the intense competition in the emerging and price-competitive markets. For instance, in January 2015, Masimo Medical Technologies India Pvt. Ltd. launched a low-cost pulse oximeter, the Sat 901+, in India. The product incorporates several advanced features to facilitate handheld as well as bedside monitoring, including acute care and alternate care settings such as long-term care facilities, homecare, and sleep laboratories. Such advancements in this sector is expected to drive the respiratory care monitoring devices market.
Surge in Global Geriatric Population
The global geriatric population has witnessed an unprecedented increase in the recent years. Aging is associated with progressive decline in lung function and increase in prevalence of respiratory diseases such as chronic obstructive pulmonary disease and asthma. The respiratory system undergoes various anatomical, physiological, and immunological changes with increase in age. The structural changes, including deformities in chest wall and thoracic spine, impair the functioning of the respiratory system and lead to complications in breathing. The incidence of respiratory diseases is expected to increase in the near future; thereby driving the global respiratory care monitoring devices market.
The key players profiled in the report include Koninklijke Philips N.V., Hamilton Medical AG, Fisher & Paykel Healthcare Limited, ResMed, Inc., Invacare Corporation, Chart Industries Inc., Dräger Safety AG & Co. KGaA, Becton, Dickinson and Company, Masimo Corporation, and Medtronic plc. The other players operating in the industry include 3B Medical, Inc., Medline Industries Inc., Acare Technology Co., Ltd., Allied Healthcare Inc., Hill-Rom Holdings Inc., and Rotech Healthcare Inc.
- The study provides an in-depth analysis of the global respiratory care devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report provides quantitative analyses of the industry for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the global respiratory care devices market helps in understanding the adoption of respiratory devices for therapeutic, monitoring, and diagnostic applications.
- Competitive intelligence highlights the business practices followed by leading market players across various geographies.
Respiratory Care Devices Market Key Segments
The global respiratory care devices market is segmented based on product, end user, and geography.
- Therapeutic Devices
- Positive Airway Pressure (PAP) Devices
- Continuous Positive Airway Pressure (CPAP) Devices
- Automatic Positive Airway Pressure (APAP) Devices
- Bi-Level Positive Airway Pressure (BPAP) Devices
- Nasal Masks
- Full-face Masks
- Nasal Pillow Masks
- Oral Masks
- Adult Ventilators
- Infant/Neonatal Ventilators
- Oxygen Concentrators
- Fixed Oxygen Concentrators
- Portable Oxygen Concentrators
- Dry Powder Inhalers
- Metered Dose Inhalers
- Soft Mist Inhaler
- Reusable Resuscitators
- Adult Resuscitators
- Infant/Neonatal Resuscitators
- Nitric Oxide Delivery Units
- Gas Analyzers
- Oxygen Hoods
- Positive Airway Pressure (PAP) Devices
- Monitoring Devices
- Pulse Oximeters
- Pediatric Pulse Oximeters
- Wrist-worn Pulse Oximeters
- Handheld Oximeter
- Fingertip Pulse Oximeter
- Table-top/bedside Pulse Oximeters
- Diagnostic Devices
- Polysomnography (PSG) Devices
- Peak Flow Meters
- Pulse Oximeters
- Consumables and Accessories
- Disposable Resuscitators
- Tracheostomy Tubes
- Nasal Cannulas
- Disposable Masks
- Other Consumables and Accessories
By End User
- Homecare Settings
- North America
- Rest of Europe
- Rest of Asia-Pacific
- South Africa
- Rest of LAMEA
Respiratory Care Devices Market Report Highlights
By END USER
Key Market Players
MASIMO CORPORATION, MEDTRONIC PLC, RESMED, INC., INVACARE CORPORATION, FISHER & PAYKEL HEALTHCARE LIMITED, BECTON, DICKINSON AND COMPANY, KONINKLIJKE PHILIPS N.V., CHART INDUSTRIES, INC., DRGER SAFETY AG & CO. KGAA, HAMILTON MEDICAL AG
The global respiratory care devices market is expected to witness significant growth in the near future, owing to the high prevalence rate of respiratory diseases across all age groups, especially the geriatric population. Presently, the market experiences steady growth, owing to the sluggish rate of product innovation. North America is expected to account for the major share in the market, on account of the high prevalence rate of respiratory diseases in this region. Asia-Pacific and LAMEA are expected to offer lucrative opportunities to market players in the near future, as the markets in the developed economies are nearing saturation due to large number of respiratory device providers. In addition, the market has experienced a paradigm shift in the recent years, because major players have focused on distributing portable products in the emerging markets, including China, India, and Brazil. LAMEA has witnessed rapid adoption of portable respiratory care devices, owing to improving reimbursement scenario for home oxygen and ventilation devices.
The growth of the global respiratory care devices market is attributed to factors such as increase in incidence of various respiratory diseases among the population, rapid urbanization, increase in pollution level, growth in geriatric population, and rise in tobacco consumption. However, large pool of undiagnosed population and risks associated with certain therapeutic devices for neonates hamper the market growth.
In the present scenario, the therapeutic devices segment accounted for the majority of the revenue share of the global market, and is expected to grow at a remarkable rate during the forecast period. This is attributed to the increased burden of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma, worldwide. In addition, automatic positive airway pressure (APAP) devices are preferred to continuous positive airway pressure (CPAP) devices, as the former are technologically advanced and quieter than the latter. Furthermore, the bilevel positive airway pressure (BPAP) devices segment is in the nascent phase of development as compared to the existing CPAP and APAP devices. Thus, technological advancements would lead to the launch of innovative products; thereby, propelling the growth of the global market.